Post-partum haemorrhage (PPH) is a leading cause of maternal death worldwide. The WOMAN trial assessed the effects of tranexamic acid (TXA) on death and surgical morbidity in women with PPH. This dataset records clinical and contextual factors surrounding the deaths of 483 women following post-partum haemorrhage.